"A great outcome": Archer Materials share price surges 14% on biochip update

Archer shares have had a stellar start to the week.

| More on:
A technical manufacturer checks his work in a high-tech lab with precision equipment in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Archer shares closed almost 14% higher at 82 cents each following a company breakthrough on its biochip technology
  • Archer successfully avchieved 15 nanometre (nm) feature size fabrication
  • The company is targeting a sub-10nm biochip fabrication which is considered best-in-class across the semiconductor industry  

The Archer Materials Ltd (ASX: AXE) share price charged ahead today following a technical progress update on the company's biochip.

At market close, the materials technology company's shares finished 13.89% higher at 82 cents apiece.

Archer progresses biochip development

Investors drove up the Archer share price after the company announced a technical breakthrough in its biochip technology.

In its release, Archer advised it has successfully achieved 15 nanometre (nm) feature size fabrication by developing advanced lithography processes.

To put that into perspective, a human hair is around 75 microns, or 75,000 nm.

This achievement represents a significant reduction in feature size that would potentially allow for billions of sensors on Archer's biochip.

Notably, the development team has attained miniaturisation from 200 nm prior to April 2021, down to the current state of 15 nm.

The company is targeting miniaturisation for a sub-10 nm biochip fabrication which is considered cutting-edge in the semiconductor industry.

The latest development marks another milestone in Archer's pursuit of commercialising its biochip technology. The global semiconductor industry is one of the most important drivers of the global economy, used in almost all technological applications.

Best-in-class capability in nanofabrication is a global competitive advantage in the multibillion-dollar point of care medical diagnostics industry. One of the reasons why there are few companies in the world developing and commercialising biochips is because it's difficult to achieve precision engineering at the nanoscale.

Archer CEO Dr Mohammad Choucair commented:

Archer's core business is the development of advanced semiconductor technology that is underpinned by the Company's nanofabrication capabilities.

Achieving 15 nanometre feature size is a great outcome. We have now prepared a suite of advanced lithography processes to reliably control fabrication for our device miniaturisation and scaling as we continue to advance towards breaking through the 10-nanometre barrier.

About the Archer share price

Despite today's gains, the Archer share price has fallen 26% in 2022.

The company's shares are more than 70% off their all-time high of $3.08 reached in mid-August last year.

Based on valuation grounds, Archer presides a market capitalisation of around $206 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A player pounces on the ball in the scoring zone of the field.
Technology Shares

Why this ASX sports tech share looks like a winner

Catapult Group has been delivering outstanding returns for investors. Will the winning streak continue?

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Technology Shares

Why this top fund manager thinks this ASX tech share can continue rising

Investors can be excited about this stock.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Broker Notes

Macquarie tips 28% upside for this ASX All Ords tech stock

Let's see what the broker is saying about this growth stock.

Read more »

happy teenager using iPhone
Share Gainers

Up 96% since April, should I still buy Life360 shares today?

A leading expert offers his verdict on the growth outlook for the surging Life360 share price.

Read more »

A female soldier flies a drone using hand-held controls.
Technology Shares

DroneShield shares charge higher on European expansion plans

This high-flying stock is surging again on Tuesday. But why?

Read more »

Human head and artificial intelligence head side by side.
Technology Shares

NextDC share price jumps 8% on big news

Another big announcement has caught the eye of investors this morning.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Technology Shares

Up 60% in two months, is it too late to buy Pro Medicus shares?

Pro Medicus has been delivering solid returns for years. Can the trend continue?

Read more »

Group of people in a gym high five each other surrounded by gym equipment.
Mergers & Acquisitions

This ASX tech stock is hitting a record high on acquisition news

The market is responding positively to this news. Let's dig deeper into it.

Read more »